EPCAM and disease recurrence: Importantly, in relapsing tumors, the CD44+ cell volume expands, and CD133+ and EpCAM+ cells proportionally proliferate, indicating that the CD44+ cell population is heterogeneous within primary PDACs and relapsing tumors.